| abstract |
The invention discloses a method for separating fibroblasts derived from human induced pluripotent stem cells and its application. Compared with the prior art, the method provided by the invention has the advantages of short separation time, high separation efficiency, and the prepared fibroblasts It has higher safety, does not need to form embryoid bodies, and does not need to replace the culture medium components many times, and a large number of high-purity fibroblasts suitable for clinical use can be obtained in a short time, which has a very good clinical application prospect. |